Suggestions
Jan Spaas
Passionate General Manager GST, part of BI
Professional Background
Jan Spaas is a highly accomplished professional in the field of veterinary medicine and comparative physiology, with a distinguished career that spans academia and industry. Currently, he serves as the General Manager at GST, a pivotal role he holds at Boehringer Ingelheim, a global leader in pharmaceuticals. His extensive experience in veterinary science, particularly in stem cell technology, positions him as an authority in this innovative field.
Before joining Boehringer Ingelheim, Jan held several significant positions at Global Stem cell Technology (GST-ANACURA). Here, he made remarkable contributions as the Chief Executive Officer (CEO), where he was responsible for steering the company towards innovative breakthroughs in stem cell therapies. His leadership at GST-ANACURA also included roles such as Head of the Stem Cell Platform and Laboratory Director. Throughout his time at GST-ANACURA, Jan was instrumental in advancing the research and development of cutting-edge stem cell applications, which have profoundly impacted both veterinary and human medicine.
Jan’s scholarly commitment to advancing the field of veterinary sciences is reflected in his tenure as a Visiting Professor at Faculteit Diergeneeskunde UGent, where he contributed to the education of future veterinary professionals. His academic roles have enabled him to bridge the gap between theoretical knowledge and practical application, ensuring that the next generation of veterinarians is well-equipped with the necessary skills and insights needed in their careers.
Education and Achievements
Jan Spaas has an impressive educational background that lays a strong foundation for his successful career. He earned his Bachelor's and Master's degrees in Veterinary Medicine from the prestigious Faculty of Veterinary Medicine at Ghent University, which is renowned for its research and clinical excellence. Following this, he pursued advanced studies in Laboratory Animal Science and Radioprotection, further expanding his specialization in veterinary sciences.
His thirst for knowledge led him to undertake a PhD program in Veterinary Sciences at the same esteemed institution. Jan's academic research has focused particularly on comparative physiology and biometrics, which has enhanced his understanding of various species and their physiological needs—crucial for his subsequent work in stem cell technology.
Jan's academic pursuits have not only fortified his expertise but have also placed him at the forefront of veterinary advancements, particularly in stem cell therapeutic applications.
Notable Achievements
- Leadership at Boehringer Ingelheim: As General Manager at GST, Jan has played a vital role in the veterinary pharmaceuticals sector, contributing to the development and dissemination of innovative treatments that enhance animal health.
- Driving Innovation at GST-ANACURA: His leadership as CEO and Head of the Stem Cell Platform at GST-ANACURA involved pioneering projects that leveraged stem cell technology for regenerative therapies, which is an evolving field with vast potential.
- Academic Contributions: As a Visiting Professor, Jan's engagement with students and faculty at UGent has inspired many future veterinarians, establishing himself as a valuable mentor and leader in the veterinary academic community.
- Research Contributions: His academic research and publications in comparative physiology have furthered the understanding of animal biology, providing insights that are vital in both clinical settings and research environments.
Jan Spaas’ expertise in veterinary medicine, combined with his leadership capabilities, research contributions, and commitment to education, make him a notable figure in the field. His journey reflects a dedication to leveraging science and innovation for improving animal health, exemplifying the vital link between veterinary science and biotechnology, particularly in the field of stem cell research and applications.
